190 related articles for article (PubMed ID: 29567820)
1. Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
Ko R; Shukuya T; Okuma Y; Tateishi K; Imai H; Iwasawa S; Miyauchi E; Fujiwara A; Sugiyama T; Azuma K; Muraki K; Yamasaki M; Tanaka H; Takashima Y; Soda S; Ishimoto O; Koyama N; Morita S; Kobayashi K; Nukiwa T; Takahashi K;
Oncologist; 2018 Oct; 23(10):1210-1217. PubMed ID: 29567820
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
Tateishi K; Ko R; Shukuya T; Okuma Y; Watanabe S; Kuyama S; Murase K; Tsukita Y; Ashinuma H; Nakagawa T; Uematsu K; Nakao M; Mori Y; Kaira K; Mouri A; Miyabayashi T; Sakashita H; Matsumoto Y; Tanigawa T; Koizumi T; Morita S; Kobayashi K; Nukiwa T; Takahashi K;
Oncologist; 2020 Apr; 25(4):e668-e674. PubMed ID: 31771990
[TBL] [Abstract][Full Text] [Related]
3. Metastatic thymic epithelial tumors: A regional cancer center experience.
Lakshmaiah KC; Chaudhuri T; Babu GK; Dasappa L; Jacob LA; Babu MCS; Rudresha AH; Lokesh KN; Rajeev LK
Indian J Cancer; 2018; 55(3):288-291. PubMed ID: 30693896
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature.
Watanabe K; Shinkai M; Goto H; Yoshikawa S; Yamaguchi N; Hara Y; Shinoda M; Moriyama Y; Rubin BK; Ishigatsubo Y; Kaneko T
Tumori; 2013; 99(4):e172-6. PubMed ID: 24326856
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes with chemotherapy for advanced thymic carcinoma.
Okuma Y; Hosomi Y; Takagi Y; Sasaki E; Hishima T; Maeda Y; Shibuya M; Okamura T
Lung Cancer; 2013 Apr; 80(1):75-80. PubMed ID: 23313005
[TBL] [Abstract][Full Text] [Related]
6. The potency of curative-intent treatment for advanced thymic carcinoma.
Okuma Y; Horio H; Hosomi Y; Watanabe K; Maeda Y; Okamura T; Hishima T
Lung Cancer; 2014 May; 84(2):175-81. PubMed ID: 24646831
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens.
Ma WL; Lin CC; Hsu FM; Lee JM; Chen JS; Huang YL; Chang YL; Chang CH; Yang JC
Cancer Med; 2022 Sep; 11(18):3445-3456. PubMed ID: 35348307
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy).
Koizumi T; Takabayashi Y; Yamagishi S; Tsushima K; Takamizawa A; Tsukadaira A; Yamamoto H; Yamazaki Y; Yamaguchi S; Fujimoto K; Kubo K; Hirose Y; Hirayama J; Saegusa H
Am J Clin Oncol; 2002 Jun; 25(3):266-8. PubMed ID: 12040285
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.
Agatsuma T; Koizumi T; Kanda S; Ito M; Urushihata K; Yamamoto H; Hanaoka M; Kubo K
J Thorac Oncol; 2011 Dec; 6(12):2130-4. PubMed ID: 21892103
[TBL] [Abstract][Full Text] [Related]
10. Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases.
Kanda S; Koizumi T; Komatsu Y; Yoshikawa S; Okada M; Hatayama O; Yasuo M; Tsushima K; Urushihata K; Kubo K; Sasabayashi M; Takamizawa A
Anticancer Res; 2007; 27(4C):3005-8. PubMed ID: 17695487
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcome of systemic treatment for metastatic or unresectable thymic carcinoma: A single institution experience.
Ho IW; Pan YL; Lai JI; Liu CY
Thorac Cancer; 2024 Feb; 15(4):339-346. PubMed ID: 38149471
[TBL] [Abstract][Full Text] [Related]
12. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
[TBL] [Abstract][Full Text] [Related]
13. Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma.
Okuma Y; Hosomi Y; Takahashi S; Maeda Y; Okamura T; Hishima T
Clin Lung Cancer; 2015 May; 16(3):221-7. PubMed ID: 25468802
[TBL] [Abstract][Full Text] [Related]
14. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
[TBL] [Abstract][Full Text] [Related]
15. Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy.
Okuma Y; Saito M; Hosomi Y; Sakuyama T; Okamura T
J Cancer Res Clin Oncol; 2015 Feb; 141(2):323-31. PubMed ID: 25146529
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatments for thymoma and thymic carcinoma: A systematic review.
Berghmans T; Durieux V; Holbrechts S; Jungels C; Lafitte JJ; Meert AP; Moretti L; Ocak S; Roelandts M; Girard N
Lung Cancer; 2018 Dec; 126():25-31. PubMed ID: 30527189
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature.
Kitami A; Suzuki T; Kamio Y; Suzuki S
Jpn J Clin Oncol; 2001 Dec; 31(12):601-4. PubMed ID: 11902491
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy and prognosis in advanced thymic carcinoma patients.
Song Z; Yu X; Zhang Y
Clinics (Sao Paulo); 2015 Dec; 70(12):775-80. PubMed ID: 26735216
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study.
Ma WL; Lin CC; Hsu FM; Lee JM; Chen JS; Hsieh MS; Chang YL; Chao YT; Chang CH; Chih-Hsin Yang J
Clin Lung Cancer; 2019 Nov; 20(6):e609-e618. PubMed ID: 31377141
[TBL] [Abstract][Full Text] [Related]
20. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
